The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies in which an Oxa directed chemotherapy was also intended [59,60] have failed in demonstrating such an improvement in the interaction with blood or normal tissue cells for their formulations (OXA-DACHPt-loaded nanoparticles and IOHNPs), being that essential for a potential application.”
From Biomimetic Magnetoliposomes as Oxaliplatin Nanocarriers: In Vitro Study for Potential Application in Colon Cancer (2020) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Jain, A., Jain, S. K., Ganesh, N., Barve, J., & Beg, A. M. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.03.002 · Cited by 214
Research works printed but not linked: 32
- 10.2174/1567201043334605 · DOI
- 10.1016/j.biomaterials.2008.12.013 · DOI
- 10.1016/S0378-5173(96)04764-3 · DOI
- 10.1016/j.jconrel.2010.02.026 · DOI
- 10.1007/978-0-387-73898-7 · DOI
- Dhawale S, 2010, Int J Pharm Tech Res, 2, 1112
- 10.1016/S0009-2509(03)00234-3 · DOI
- 10.1016/j.ces.2007.08.006 · DOI
- 10.1016/j.ejphar.2009.06.066 · DOI
- Jain A, 2007, J Pharm Pharm Sci, 10, 86
- 10.1038/nrd2683 · DOI
- 10.1038/sj.cdd.4401187 · DOI
- 10.1038/nbt.1549 · DOI
- 10.1002/adfm.201401583 · DOI
- 10.1016/j.biomaterials.2009.09.036 · DOI
- 10.1016/j.carbpol.2012.12.032 · DOI
- 10.1016/j.semcancer.2005.06.005 · DOI
- 10.1200/JCO.2010.34.0760 · DOI
- Mohideen B, 2013, Int J Biol Pharm Res, 4, 533
- 10.1016/S0939-6411(00)00087-4 · DOI
- Radulovic S, 1991, Cancer Res, 51, 6006
- 10.1200/JCO.2003.11.045 · DOI
- 10.1038/nature03794 · DOI
- 10.1021/bm700753q · DOI
- Tummala S, 2014, Indo Am J Pharm Res, 4, 3579
- 10.1016/j.jsps.2014.11.010 · DOI
- 10.1021/am406012g · DOI
- 10.1056/NEJMp1101548 · DOI
- 10.1021/nn800275r · DOI
- Zhang L, 2015, Int J Nanomed, 10, 2101
- 10.1016/j.jconrel.2007.07.016 · DOI
- 10.1016/j.biomaterials.2014.12.028 · DOI
Cited by
Sorted by citations
Garcia-Pinel, B., Jabalera, Y., Ortiz, R., Cabeza, L., Jimenez-Lopez, C., Melguizo, C., & Prados, J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060589 · Cited by 40
Metadata
- Authors
- Tummala, S., Gowthamarajan, K., Satish Kumar, M. N., & Wadhwani, A.
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2015-09-17
- Volume
- 23
- Issue
- 5
- Pages
- 1773-1787
- ISSN
- 1071-7544
- 1521-0464
- Cited by
- 61
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors. https://app.cochat.ai/papers/10.3109/10717544.2015.1084400
- The paper
- Tummala, S., Gowthamarajan, K., Satish Kumar, M. N., & Wadhwani, A. (2016). Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors. Drug Delivery. https://doi.org/10.3109/10717544.2015.1084400
